Stroke Management
M1 occlusion
OEF increase
Oncology
Glioblastoma
tumor recurrence
OEF increase
Have you ever heard about Oxygen Extraction Fraction (OEF)? It’s an important biomarker in Cercare Medical Neurosuite software that ensures high-quality perfusion maps.

In the world of advanced diagnostic imaging, the measurement of OEF is emerging as a critical indicator in diverse clinical settings, including stroke and oncology. This parameter isn’t just about numbers; it translates into potentially lifesaving insights for patients suffering from acute and complex conditions. 

Stroke Management

In cases of ischemic stroke, OEF helps us understand the efficiency of oxygen utilization in compromised brain regions. Studies have shown that during a stroke, the affected brain areas may have altered OEF due to restricted blood flow. By closely monitoring these changes, physicians can make more informed decisions about interventions like thrombolysis or mechanical thrombectomy, potentially improving patient outcomes.

Oncology Insights

In oncology, particularly in conditions like recurrent glioblastoma, understanding OEF is crucial for evaluating tumor microenvironments. Treatment with drugs like Bevacizumab, aimed at normalizing tumor blood vessels, impacts OEF measurements. Surprisingly, despite the normalization of these vessels, overall tumor oxygenation may worsen, highlighting the complex interplay between tumor biology and therapeutic interventions. This insight prompts a re-evaluation of treatment strategies, aiming for therapies that not only target tumor vessels but also improve the tumor oxygen profile.
🩺💡 Are you leveraging OEF in your clinical practice? How are you integrating these insights into your treatment plans? Get in contact with Cercare Medical to learn more about our high-quality perfusion maps based on a range of advanced biomarkers.
#StrokeCare #Oncology #MedicalImaging #PerfusionMaps #OxygenExtractionCapacity #Biomarkers #HealthcareInnovation

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
© 2025 Cercare Medical. All rights reserved.

CLINICAL USE CASES AND TECHNICAL HIGHLIGHTS


CLINICAL USE CASES
  • Assess outcomes post-intervention: detect missed stenoses, distal occlusions, or microvascular disturbances.
  • Guide complementary therapies on the spot based on perfusion status.
  • May detect the no-reflow phenomenon — providing insight into cases where recovery may fail despite successful thrombectomy.
  • Potentially enables direct-to-angio workflows.

TECHNICAL HIGHLIGHTS
  • Full set of perfusion markers: CBF, CBV, MTT.
  • Advanced oxygen metabolism imaging: OEF, CMRO₂.
  • Reliable results with as few as 5 CBCT acquisitions (bolus injection timing protocol very important).
  • Integrated with Siemens and Philips systems; GE/Canon under evaluation.

CBCT Imaging

Side-by-side comparison: The left-hand side is the raw CBCT data, while the right-hand side panel is the pre-processed data.
Using CMN software in the angio suite delivers results comparable to conventional CT/MR perfusion.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.

Thank you for uploading your DICOM files.

Your submission has been received successfully.

Next steps:

  • Our team will analyze the uploaded data.
  • A Cercare Medical representative will reach out to you once the analysis is complete.
  • Rest assured that all files will be deleted immediately after use, in line with our data protection policies.
Perfusion Summit 2026
Date: 26 March 2026, Thursday
Time: 10:15 - 17:40 (CET)
Venue: Concorde Hall, Hilton Paris Hotel, CDG
Participation is Optional

Hands-On Workshops
Date: 27 March 2026

Workshop selection is optional and does not confirm registration. Confirmation and further details will be provided in January 2026. Please note that seating is limited.
By participating in this event, you consent to the use of your image, voice, and likeness in photographs, and videos for promotional purposes, in accordance with GDPR regulations.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)

Request a demo

Let us give you a tour around our solution.

Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.
})